Navigation Links
Kuvan Receives Marketing Approval in the European Union
Date:12/9/2008

h is currently in Phase 2 clinical development for the treatment of peripheral arterial disease and sickle cell disease, and PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase 1 clinical development for the treatment of PKU. For additional information, please visit http://www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

Forward-Looking Statement

This press release contains forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc., including, without limitation, statements about: the continued development and commercialization of Kuvan and BioMarin's other products and product candidates and actions by regulatory authorities. These forward-looking statements are predictions and involve risks and uncertainties such that actual results may differ materially from these statements. These risks and uncertainties include, among others: our success in the continued commercialization of Kuvan; the content and timing of decisions by the U.S. Food and Drug Administration, the European Commission and other regulatory authorities concerning each of the described products and product candidates; and those factors detailed in BioMarin's filings with the Securities and Exchange Commission, including, without limitation, the factors contained under the caption "Risk Factors" in BioMarin's 2007 Annual Report on Form 10-K, as amended, and the factors contained in BioMarin's reports on Form 10-Q and Form 8-K. Stockholders are urged not to place undue reliance on forward-looking statements, which speak only as of the date hereof. BioMarin is under no obligation, and expressly disclaims any obligation to update or alter any forward-looking statement, whether as a result of new information, future events or otherwise.

BioMarin(R), Naglazyme(R) and Kuvan(R
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Kuvan Receives Positive Opinion From CHMP for European Approval
2. Kuvan, Naglazyme and Aldurazyme Data to Be Presented at the 57th Annual Meeting of the American Society of Human Genetics
3. Exclusive Rights to Kuvan(TM) Data Licensed to Asubio Pharma in Japan
4. Align Technology Receives Expanded Regulatory Approval in Japan
5. Adecco Receives Honor From Alcon Laboratories
6. ANA598 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection
7. EastMed Inc. receives FDA clearance to market uresta(TM) in the U.S.
8. SuperGen Receives Clearance to Begin Clinical Trials With SGI-1776, a PIM Inhibitor
9. Serica Technologies Receives ISO Certification, Meets International Standards for Medical Device Manufacturing
10. Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission of Important IMVAMUNE(R) Data to The U.S. Health Authorities
11. Cellectricon Receives Milestone Order for Cellaxess(R)HT, the Worlds First High Throughput RNAi Screening System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 10, 2014 Terascala, the industry ... that Alan Swahn, a former vice president of product ... as vice president of marketing. Terascala’s software when combined ... NetApp create the highest performance and most reliable solutions ... to guide Terascala’s channel expansion and broaden its product ...
(Date:7/10/2014)... Calabasas, CA (PRWEB) July 10, 2014 ... academic institutions and professional associations, addressed the challenges of ... & Medical Device Industries” through strategic sourcing. Describing the ... ) with the Supply Chain Management Institute ( SCMI) ... the event on June 24 at the Kroc Institute ...
(Date:7/10/2014)... , July 10, 2014 Research and ... of the "International Photonic Integrated Circuit (Monolithic ... to 2019" report to their offering. ... The concept of photonic integration traces its roots ... The promise of photonic integration went unexplored and ...
(Date:7/10/2014)... published today in the journal PNAS (Proceedings of ... time of day and sleep deprivation have a significant ... when looking at the best time of day to ... and for administering medicines effectively. , Researchers from the ... London, investigated the links between sleep deprivation, body clock ...
Breaking Biology Technology:Terascala Expands Executive Team 2Terascala Expands Executive Team 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 2Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 4International Photonic Integrated Circuit (Monolithic Integration, Hybrid Integration, Module Integration) Market - Forecasts to 2019 2Time of day crucial to accurately test for diseases, new research finds 2
... but its repair could actually increase warming in the southern hemisphere, ... The Antarctic ozone ... but the discovery of a previously undiscovered feedback shows that it ... the past two decades. High-speed winds in the area ...
... , Jan. 25 Novavax, Inc. (Nasdaq: ... company will be presenting at the upcoming Phacilitate Vaccine Forum ... at the Grand Hyatt, Washington, D.C.  Mr. ... Alliances will be participating in a Focus Session: Fast ...
... AMSTERDAM, The Netherlands ... (Euronext: AMT), a leader in the field of,human ... the official,marketing authorisation process for its lead product ... The submission,of the Glybera(R) Marketing Authorisation Application (MAA), ...
Cached Biology Technology:Ozone hole healing could cause further climate warming 2NOVAVAX to Present at Phacilitate Vaccine Forum Washington 2010 2EMA Starts Formal Review of Glybera(R) Dossier 2EMA Starts Formal Review of Glybera(R) Dossier 3
(Date:7/11/2014)... German . ... the refraction of X-rays through a specimen instead of ... method are often of much higher quality than those ... Prof. Franz Pfeiffer are particularly interested in developing new ... X-ray phase-contrast imaging. One main goal is to make ...
(Date:7/11/2014)... researchers at the National Institute of Standards and ... their work more effectively, they often prove that ... was the case recently for M. Lorna De ... the growing specialization of glycomics. Glycomics is the ... glycans that are attached to proteins and lipids ...
(Date:7/11/2014)... China Researchers from Salk Institute for Biological Studies, ... evaluated the safety and reliability of the existing ... new method, TALEN-HDAdV, which could significantly increased gene-correction ... This study published online in Cell Stell ... stem cell-based gene therapy. , The combination of ...
Breaking Biology News(10 mins):New simple setup for X-ray phase contrast 2A new genome editing method brings the possibility of gene therapies closer to reality 2
... IOF World Congress on Osteoporosis 2008 (IOF WCO), to ... registration to benefit from special early bird rates. The ... 3-7, 2008, is the worlds largest scientific congress devoted ... to IOF Members, Non-Members and Students or Fellows, with ...
... hereditary disorder that strongly predisposes carriers to develop cancer ... Asian female, report researchers today at the American Association ... Generally, a person should have two normal copies ... the disorder known as Li-Fraumeni syndrome (LFS), one defective ...
... announced the results of a systematic effort to map ... cause of cancer deaths. Appearing in the November 4 ... provides a comprehensive view of the abnormal genetic landscape ... regions that are frequently gained or lost in human ...
Cached Biology News:Rare cancer-causing syndrome found, for the first time, in Singapore 2Genome study charts genetic landscape of lung cancer 2Genome study charts genetic landscape of lung cancer 3
... Fujifilm Life Science LAS-3000mini is a ... to chemiluminescence applications, and the perfect ... Fuiji 's LAS-3000 provides significantly improved ... , Glowell calibration standards validate that ...
Designed for use with the Agencourt CleanSEQ and Agencourt AMPure 384-well SPRI reagent kits. For use with 384-well thermal cycling plates....
... ScriptCap™ m7G Capping system ... and all of the components ... 0 on the end of ... These kits feature high efficiency ...
... Fujifilm Life Science FLA-5100 imaging system allows ... large as 40 x 46cm at a ... This system is especially suitable for protein ... array analysis for genomics., Fuji s FLA-5100 ...
Biology Products: